Warren Glaab

Cutting Edge Congress
,

Dr. Warren Glaab has worked within Nonclinical Drug Safety at Merck Sharp & Dohme, Inc. for 27 years.  Most recently he has served as Distinguished Scientist of Safety Biomarkers, involved with providing safety biomarker development support to Safety Assessment, incorporating new model systems and technologies including genomics and proteomics, and investigative toxicology research solutions.  Previous experience within the Department of Investigative Laboratory Sciences group in Safety Assessment included novel assay development and investigational studies to better understand toxicity mechanisms.  He earned his Ph.D. in Toxicology at the University of North Carolina at Chapel Hill, conducted research at the National Institute of Environmental Health Sciences in Research Triangle Park, and completed two postdoctoral positions at National Institute of Environmental Health Sciences and at Merck Research Laboratories in West Point, PA, USA.